AB
Healthcare & Life Sciences
Abzena Bio
United States
Abzena Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Abzena Bio
Abzena Bio is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops antibody-drug conjugates (ADCs), which are engineered antibodies linked to cytotoxic agents, designed as targeted cancer therapeutics.
Explore Abzena Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.